09:51 AM EST - GLG Life Tech Corporation : announced its patent application for the separation methodologies of rebaudioside B, rebaudioside D and steviolbioside has been accepted by the State Intellectual Property Bureau of the People's Republic of China. GLG Life Tech Corporation
shares T.GLG are trading up $0.32 at $11.00.
